BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy

NCT01873404 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
183
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen